Yili Chuannig Biotechnology Co (SZSE:301301) Total Stockholders Equity : ¥7,320 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Yili Chuannig Biotechnology Co Total Stockholders Equity?

Yili Chuannig Biotechnology Co's Total Stockholders Equity for the quarter that ended in Mar. 2024 was ¥7,320 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Yili Chuannig Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥3.29. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Yili Chuannig Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.26.

Yili Chuannig Biotechnology Co Total Stockholders Equity Historical Data

The historical data trend for Yili Chuannig Biotechnology Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yili Chuannig Biotechnology Co Total Stockholders Equity Chart

Yili Chuannig Biotechnology Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

4,430.94

4,659.94

4,771.28

6,204.49

6,960.48

Yili Chuannig Biotechnology Co Quarterly Data
	Dec18	Dec19	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial											6,379.93	6,394.11	6,652.05	6,960.48	7,320.33

Yili Chuannig Biotechnology Co (SZSE:301301) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Yili Chuannig Biotechnology Co's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(7320.331	-	0)	/	2227.16
	=	3.29

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Yili Chuannig Biotechnology Co's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1233.74	+	676.701)	/	7320.331
	=	0.26

Yili Chuannig Biotechnology Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Yili Chuannig Biotechnology Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Yili Chuannig Biotechnology Co (SZSE:301301) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Yili Chuannig Biotechnology Co Ltd (SZSE:301301) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 516, Almatua Village, Yining Park, Horgos Economic Development Zone, Xinjiang, Ili, CHN, 835000

Website

http://www.klcnsw.com

Yili Chuannig Biotechnology Co Ltd adopts the most advanced and mature international biological fermentation, chemical extraction, enzymatic hydrolysis, control and energy saving, and environmental protection technology. The main products of the company include erythromycin thiocyanate, cephalosporin intermediates, penicillin intermediates, and crude ursodeoxycholic acid.

Yili Chuannig Biotechnology Co (SZSE:301301) Headlines

No Headlines